Patients with chronic obstructive pulmonary disease usually do not need long-term nebulization.
Acute exacerbations of chronic obstructive pulmonary disease may require nebulized inhalation therapy, such as nebulized inhalation of terbutaline budesonide suspension. Treatment by nebulized inhalation can help reduce the patient’s symptoms and promote recovery.
However, long-term nebulized inhalation therapy is usually not recommended for patients with chronic obstructive pulmonary disease (COPD) when their condition is stable. During the stable period of chronic obstructive pulmonary disease, you can follow the doctor’s instructions to regularly inhale some packaged aerosol-type drugs, such as tiotropium bromide, indacaterol griseofulvin bromide, budesonide formoterol aerosol and so on.
In summary, nebulized inhalation therapy will have a certain effect on the acute stage of chronic obstructive pulmonary disease, but it needs to be used reasonably under the guidance of the doctor, rather than as a long-term maintenance treatment program.